Principal Financial Group Inc Atara Biotherapeutics, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$0.44 - $1.22 $2,954 - $8,192	-6,715 Reduced 20.16%	26,591 $18,000
Q4 2023 Feb 07, 2024	SELL	$0.23 - $1.74 $497 - $3,760	-2,161 Reduced 6.09%	33,306 $16,000
Q3 2023 Nov 02, 2023	BUY	$1.41 - $2.31 $7,614 - $12,474	5,400 Added 17.96%	35,467 $52,000
Q2 2023 Aug 07, 2023	BUY	$1.5 - $3.04 $4,980 - $10,092	3,320 Added 12.41%	30,067 $48,000
Q1 2023 May 09, 2023	BUY	$2.8 - $5.46 $9,170 - $17,881	3,275 Added 13.95%	26,747 $77,000
Q4 2022 Feb 09, 2023	BUY	$2.85 - $5.18 $8,766 - $15,933	3,076 Added 15.08%	23,472 $76,000
Q3 2022 Nov 09, 2022	BUY	$2.85 - $8.73 $12,463 - $38,176	4,373 Added 27.29%	20,396 $77,000
Q2 2022 Aug 10, 2022	BUY	$4.69 - $9.84 $75,147 - $157,666	16,023 New	16,023 $124,000
Q1 2022 May 09, 2022	SELL	$8.44 - $16.89 $85,632 - $171,365	-10,146 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$14.7 - $19.89 $92,698 - $125,426	-6,306 Reduced 38.33%	10,146 $160,000
Q3 2021 Nov 09, 2021	SELL	$11.99 - $17.9 $31,977 - $47,739	-2,667 Reduced 13.95%	16,452 $294,000
Q2 2021 Aug 10, 2021	SELL	$12.89 - $16.58 $151,560 - $194,947	-11,758 Reduced 38.08%	19,119 $297,000
Q1 2021 May 10, 2021	BUY	$14.0 - $20.72 $2,156 - $3,190	154 Added 0.5%	30,877 $443,000
Q4 2020 Feb 08, 2021	BUY	$12.67 - $26.23 $249,713 - $516,967	19,709 Added 178.94%	30,723 $603,000
Q3 2020 Nov 06, 2020	SELL	$11.92 - $15.87 $6,508 - $8,665	-546 Reduced 4.72%	11,014 $142,000
Q2 2020 Aug 05, 2020	BUY	$7.53 - $14.93 $87,046 - $172,590	11,560 New	11,560 $168,000
Q2 2019 Aug 12, 2019	SELL	$19.05 - $41.04 $239,744 - $516,488	-12,585 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$28.4 - $41.74 $172,615 - $253,695	6,078 Added 93.41%	12,585 $501,000
Q4 2018 Feb 14, 2019	SELL	$30.9 - $42.97 $224,643 - $312,391	-7,270 Reduced 52.77%	6,507 $226,000
Q3 2018 Nov 14, 2018	BUY	$35.05 - $43.5 $70,520 - $87,522	2,012 Added 17.1%	13,777 $570,000
Q2 2018 Aug 13, 2018	BUY	$35.15 - $51.45 $220,495 - $322,745	6,273 Added 114.22%	11,765 $0
Q1 2018 May 14, 2018	BUY	$18.0 - $48.35 $98,856 - $265,538	5,492 New	5,492 $214,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account